In a review of pediatric and adult distal cerebrospinal fluid shunt failures, the distal catheters were found to have deteriorated to the point of malfunction in 7 individuals after intervals of over 7 years. All cases presented in the first two decades of life with a duration of symptoms ranging from 1 to 62 days. The mechanism of shunt failure was assessed by radionuclide shuntogram study and at surgery. Degradation of catheter material led to irregular attenuation and fracture of the catheter wall with diffuse leakage of radionuclide into surrounding tissues. The catheter length of most chronic duration following implant was inevitably affected. Radionuclide shuntogram study of the distal catheter clearly identified the nature of the problem by showing an irregular outline of the catheter lumen due to spread of radioactivity into the surrounding soft tissues. Occasionally, intense foci of activity were identified at single or multiple sites where the catheter wall was grossly attenuated or fractured, resulting in cessation of catheter flow further distally. The biodegradability of distal shunt catheters leading to malfunction must be considered when assessing a young individual with features of hydrocephalus and a chronically implanted catheter length. Radionuclide shuntogram study is a convenient means of assessing the problem.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.